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ife and death decisions are made by integrating a
variety of apoptotic and survival signals in mamma-
lian cells. Therefore, there is likely to be a common
mechanism that integrates multiple signals adjudicating
between the alternatives. In this study, we propose that
14-3-3  represents such an integration point. Several
proapoptotic proteins commonly become associated with
14-3-3 upon phosphorylation by survival-mediating ki-
nases such as Akt. We reported previously that cellular
stresses induce c-Jun NH
 
2
 
-terminal kinase (JNK)–mediated
14-3-3
 
 
 
 phosphorylation at Ser184 (Tsuruta, F., J. Suna-
yama, Y. Mori, S. Hattori, S. Shimizu, Y. Tsujimoto, K.
L
 
Yoshioka, N. Masuyama, and Y. Gotoh. 2004. EMBO
 
 J
 
.
23:1889–1899). Here, we show that phosphorylation of
14-3-3 by JNK releases the proapoptotic proteins Bad
and FOXO3a from 14-3-3 and antagonizes the effects
of Akt signaling. As a result of dissociation, Bad is de-
phosphorylated and translocates to the mitochondria,
where it associates with Bcl-2/Bcl-x
 
L
 
. Because Bad and
FOXO3a share the 14-3-3–binding motif with other
proapoptotic proteins, we propose that this JNK-mediated
phosphorylation of 14-3-3 regulates these proapoptotic
proteins in concert and makes cells more susceptible to
apoptotic signals.
 
Introduction
 
The balance between signals promoting survival and apoptosis
is important for determining cell fate. Survival signals raise the
threshold above which apoptotic signals can induce the ma-
chinery of cell death, and, accordingly, a reduction in survival
signals results in a high sensitivity of the cell to apoptotic sig-
nals. A key to understanding cell death regulation, therefore, is
to reveal the molecular mechanisms by which survival and
apoptotic signals integrate.
The 14-3-3 proteins are a family of phospho-Ser/phospho-
Thr–binding molecules that play essential roles in many bio-
logical processes, including the regulation of cell death (van
Hemert et al., 2001; Masters et al., 2002; Yaffe, 2002). 14-3-3
promotes cell survival by sequestering and inactivating several
proapoptotic proteins, including Bad and FOXO3a, after their
phosphorylation by survival-inducing kinases such as Akt (Zha
et al., 1996; Datta et al., 1997; del Peso et al., 1997; Biggs et
al., 1999; Brunet et al., 1999; Kops et al., 1999; Zhang et al.,
1999; Masuyama et al., 2001; Masters et al., 2002; Basu et al.,
2003). Indeed, the reduction of available 14-3-3 sensitizes cells
to apoptotic signals, and overexpression of 14-3-3 renders cells
resistant to apoptotic signals (Chan et al., 1999; Zhang et al.,
1999; Xing et al., 2000; Masters and Fu, 2001; Samuel et al.,
2001; Nomura et al., 2003; Tsuruta et al., 2004). The level of
available 14-3-3 may, therefore, be crucial for determining the
threshold above which apoptotic signals can initiate the program.
14-3-3 appears to be modulated by phosphorylation.
Phosphorylated forms of 14-3-3
 
 
 
 and 
 
 
 
 at Ser186 and 184, re-
spectively, are abundantly present in brain tissue (Aitken et
al., 1995). We found that 14-3-3
 
 
 
 and 
 
 
 
 isoforms are phos-
phorylated at their respective phosphorylation sites by c-Jun
NH
 
2
 
-terminal kinase (JNK; Tsuruta et al., 2004). This finding
prompted us to examine whether phosphorylation of 14-3-3
may have any impact on the regulation of cell death because
JNK has been suggested to play a key role in stress-induced
apoptosis in a context-dependent manner (Yang et al., 1997;
Tournier et al., 2000; Lei et al., 2002; Deng et al., 2003; Kuan
et al., 2003). It is important to note that phosphorylation of
14-3-3
 
 
 
 causes the dissociation of Bax from 14-3-3, leading to
Bax translocation to the mitochondria and to apoptosis (Tsuruta
et al., 2004). The expression of mutants lacking phosphorylation
sites (Ser184A of 14-3-3
 
 
 
 or Ser186A of 14-3-3
 
 
 
) effectively
attenuates cell death that is induced by stress-activated JNK,
suggesting that 14-3-3 is a major target of JNK in the induction
of cell death. However, Bax is not a typical 14-3-3 ligand in the
sense that this binding does not require the common ligand-
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binding groove and does not depend on ligand (Bax) phos-
phorylation (Nomura et al., 2003). Thus, it is unclear whether
phosphorylation of 14-3-3 also affects the association of “typi-
cal” 14-3-3 ligands, which usually contain the 14-3-3–binding
motif RSXpSXP or RXXXpSXP (Muslin et al., 1996; Yaffe et
al., 1997). Because Ser184 is located near the ligand-binding
groove, the phosphorylation of this residue might regulate the
association of many typical 14-3-3 ligands, including the afore-
mentioned proapoptotic proteins. To investigate the hypothesis
that the JNK-mediated phosphorylation of 14-3-3 may contrib-
ute to cell death by regulating typical 14-3-3 ligands in addition
to Bax, we examined the effect of 14-3-3 phosphorylation on
the association of Bad, which binds to the common ligand-
binding groove of 14-3-3 upon Bad phosphorylation.
Bad is a “BH3-only” member of the Bcl-2 family (Danial
and Korsmeyer, 2004). Survival factors suppress the proapop-
totic function of Bad by phosphorylation at Ser112, 136, and
155 (Zha et al., 1996; Datta et al., 2000; Lizcano et al., 2000;
Zhou et al., 2000). Phosphorylation of Ser112 and 136 creates
the 14-3-3–binding motifs RHSpS
 
112
 
YP and RSRpS
 
136
 
AP, re-
spectively, and the consequent interaction with 14-3-3 leads to
the cytoplasmic sequestration and inactivation of Bad. Akt,
Pak-1, and p70S6 kinase appear to mediate the survival fac-
tor–induced phosphorylation of Bad at Ser136, whereas Rsk,
mitochondria-associated protein kinase A, Pak-1 and -5, and
Pim-1 are responsible for phosphorylation at Ser112 (Datta et
al., 1997; del Peso et al., 1997; Blume-Jensen et al., 1998;
Bonni et al., 1999; Harada et al., 1999, 2001; Tan et al., 1999;
Schurmann et al., 2000; Shimamura et al., 2000; Cotteret et al.,
2003; Aho et al., 2004). The dephosphorylated form of Bad is
targeted to the mitochondria, where it causes apoptosis by
binding and inactivating Bcl-2/Bcl-x
 
L
 
 (Wang et al., 1999).
Thus, survival factors regulate the interaction between Bad
and 14-3-3 by regulating Bad phosphorylation. However, it re-
mains to be determined whether the interaction between Bad
and 14-3-3 is also regulated by the phosphorylation state of
14-3-3. Because Bad and JNK are both implicated in stress-
induced cell death (Yang et al., 1997; Tournier et al., 2000;
Datta et al., 2002; Lei et al., 2002; Deng et al., 2003; Kuan et
al., 2003), we focused on Bad as a potential target for JNK-
mediated apoptotic signals.
 
Results
 
JNK promotes the dissociation of Bad 
from 14-3-3 proteins in vivo
 
Ser186 of 14-3-3
 
 
 
 and 
 
 
 
 (corresponding to Ser184 of 14-3-3
 
 
 
)
is a surface residue located at the NH
 
2
 
 terminus of helix 8 near
the top of the ligand-binding groove (Fig. 1 a; Liu et al., 1995;
Xiao et al., 1995). We examined whether phosphorylation of
this site would affect the association of Bad, which is a typical
14-3-3 ligand. We first examined whether the activation of
JNK affects the interaction between 14-3-3 and Bad. When en-
dogenous Bad was immunoprecipitated from lysates of COS-1
cells, endogenous 14-3-3 was coprecipitated (Fig. 1 b). How-
ever, when COS-1 cells were treated with the protein synthesis
inhibitor anisomycin, the amount of 14-3-3 that coprecipitated
with Bad was markedly reduced (Fig. 1 b). Coprecipitation of
Bad with 14-3-3 was also diminished by UV irradiation of
HCT116 cells (Fig. 1 c). We chose anisomycin and UV treat-
ment in these experiments because these cellular stresses are
known to activate JNK effectively and require JNK activation
Figure 1. JNK promotes the dissociation of Bad from 14-3-3 in
vivo. (a) The putative JNK phosphorylation site of 14-3-3  is ad-
jacent to the ligand-binding groove, which is shown in red. The
right panel is a close-up view of the region (white box, left) sur-
rounding the putative phosphorylation site (Ser184), which is
shown in yellow. (b) COS-1 cells were transfected with the indi-
cated plasmids and were incubated for 3 h in the absence or
presence of 10  g/ml anisomycin. Cell lysates were subjected to
immunoprecipitation (IP) with antibodies to Bad or normal rabbit
IgG (NRI). (c) HCT116 cells were transfected with the indicated
plasmids and were irradiated by 50 J/m
2 UV for 6 h. Cell lysates
were subjected to immunoprecipitation with antibodies to 14-3-3 
or normal goat IgG (NGI). (d) Cells were transfected and cultured
as described in b and c. Cell lysates were subjected to immuno-
blot analysis with the indicated antibodies. (e) COS-1 cells were
transfected for 18 h with expression vectors for MKK7-JNK and
p35 as indicated. Cell lysates were subjected to immunoprecipi-
tation with antibodies to Bad. (b–e) The resulting precipitates
were subjected to immunoblot analysis (IB) with the indicated an-
tibodies. The same results were obtained in three independent
experiments. 
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to induce cell death in mouse embryonic fibroblasts (Tournier
et al., 2000) and HCT116 cells (see Fig. 5, a and b). We next
examined whether this cellular stress-induced dissociation be-
tween 14-3-3 and Bad was mediated by the activation of en-
dogenous JNK. The expression of a dominant negative (DN)
JNK or an inhibitory peptide for JNK (called JNK-binding
domain [JBD]; Dickens et al., 1997) abrogated the ability of
anisomycin  or UV treatment to induce the dissociation be-
tween 14-3-3 and Bad, demonstrating a prerequisite role of
JNK in this event (Fig. 1, b and c). Anisomycin treatment of
COS-1 cells or UV irradiation of HCT116 cells resulted in
phosphorylation of the JNK substrate c-Jun, and the expression
of DN-JNK or JBD blocked these effects (Fig. 1 d). We then
asked whether the expression of active JNK is sufficient to in-
duce the dissociation between 14-3-3 and Bad. The expression
of a constitutively active (CA) form of JNK (MKK7-JNK wild
type [WT]), but not that of a kinase negative (KN) JNK
(MKK7-JNK [KN]), resulted in a decrease in the amount of
14-3-3 that coprecipitated with Bad (Fig. 1 e). Although JNK
induces activation of the caspase cascade (Lei et al., 2002;
Tsuruta et al., 2004), this effect of MKK7-JNK (WT) was not
influenced by the coexpression of p35, a pan-caspase inhibitor,
suggesting that JNK promotes the dissociation of Bad from
14-3-3 independently of caspase activation (Fig. 1 e).
 
JNK-mediated phosphorylation of 14-3-3 
results in the release of Bad from 14-3-3 
in vitro
 
Next, we asked whether the JNK-induced dissociation of Bad
from 14-3-3 is dependent on the phosphorylation state of 14-3-3
in an in vitro reconstitution assay. We performed GST pull-
down experiments to detect the association between recombi-
nant GST-tagged 14-3-3
 
 
 
 and His-tagged Bad proteins (Fig. 2).
Bad interacts with 14-3-3 proteins only when it is phosphory-
lated at Ser112 and/or 136 (Zha et al., 1996). To phosphorylate
Bad at Ser136, we preincubated recombinant Bad with CA-Akt
that was immunoprecipitated from COS-1 cells. We confirmed
that Bad coprecipitated with GST–14-3-3
 
 
 
, but not with GST
alone, only when it was preincubated with CA-Akt in the pres-
ence of ATP (Fig. 2 a). We then performed the phosphorylation
of GST–14-3-3
 
 
 
 by MKK7-JNK (WT) before the GST pull-
down experiments with Akt-phosphorylated Bad and found that
this phosphorylation of 14-3-3
 
 
 
 reduced the amount of Bad that
was coprecipitated with GST–14-3-3
 
 
 
. In contrast, when the
Ser184A mutant of GST–14-3-3
 
 
 
 was used, similar amounts of
Bad were precipitated with or without MKK7-JNK (WT) prein-
cubation. These results indicate that 14-3-3
 
  
 
phosphorylation at
Ser184 by JNK reduces its affinity for Bad (Fig. 2 a).
Recent studies have shown that JNK and Cdc2 phosphor-
ylate Bad at Ser128 in primary cerebellar granule neurons, and
phosphorylation of Bad inhibits the interaction of Bad with
14-3-3 (Donovan et al., 2002; Konishi et al., 2002). In addition,
JNK phosphorylates mouse Bad at Thr201, although this site is
not conserved in human Bad (Yu et al., 2004). Therefore, we
investigated whether phosphorylation of 14-3-3
 
 
 
 at Ser184 can
lead to the dissociation of Bad from 14-3-3 regardless of the
phosphorylation state of Bad at Ser128 or Thr201. We found
that any of the recombinant mutant Bads (Bad Ser128A,
Thr201A, or Ser128A-Thr201A) could interact with 14-3-3
 
 
 
when phosphorylated by active Akt and that they dissociated
from 14-3-3
 
 
 
 when 14-3-3
 
 
 
 was phosphorylated by MKK7-
JNK (WT; Fig. 2 b and Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200409117.DC1). Therefore, the JNK-
mediated phosphorylation of 14-3-3 can induce the dissocia-
tion of Bad independently of the Ser128 and Thr201 phosphor-
ylation of Bad.
 
JNK promotes Bad translocation to 
mitochondria
 
Bad is localized mostly in the cytoplasm but redistributes to the
mitochondria in response to survival factor deprivation (Li et
al., 2004). Because 14-3-3 is regarded as a cytoplasmic anchor
for Bad (Muslin and Xing, 2000) and we found that the JNK-
mediated phosphorylation of 14-3-3 releases Bad from 14-3-3,
we hypothesized that JNK might regulate the localization of
Bad. To investigate this, we used Myc-tagged Bad (Myc-Bad).
In all of the experiments with Myc-Bad, p35 was cotransfected
to prevent caspase activity induced by the overexpression of
Myc-Bad. In healthy cells, a large proportion of Myc-Bad local-
ized in the cytoplasm, whereas a small proportion colocalized
with MitoTracker CMXRos, as judged by immunocytochemical
analysis (Fig. 3 a). We found that the expression of MKK7-JNK
(WT), but not MKK7-JNK (KN), resulted in the translocation
of Myc-Bad to the mitochondria. To confirm the effect of JNK
on promoting Bad translocation, we examined the distribution
Figure 2. JNK-mediated phosphorylation of 14-3-3 results in the release
of Bad from 14-3-3 in vitro. (a and b) GST-tagged proteins were subjected
to an in vitro kinase assay with His-tagged MKK7-JNK and were incu-
bated with His-tagged Bad wild type (WT; a) or Ser128A (b) that was pre-
incubated with or without CA-Akt immune complex. The GST proteins
were precipitated using glutathione–Sepharose beads. The amount of Bad
protein coprecipitated with either GST or GST–14-3-3  was determined by
immunoblot analysis (IB) with the indicated antibodies. The same results
were obtained in at least two independent experiments. 
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of endogenous Bad by subcellular fractionation after transfec-
tion of COS-1 cells with MKK7-JNK constructs (Fig. 3 b). The
amount of endogenous Bad that was detected in the mitochon-
drial fraction was increased by the expression of MKK7-JNK
(WT). In contrast, the expression of MKK7-JNK (KN) did not
have these effects. In this assay, the abundance of the mitochon-
drial marker F
 
1
 
F
 
0
 
-ATPase subunit 
 
 
 
 and that of the cytosolic
marker 
 
 
 
-tubulin in these fractions were unaffected by the
expression of either construct. Although MKK7-JNK (WT)
resulted in the activation of caspase-3 (Lei et al., 2002; Tsuruta
et al., 2004), the coexpression of p35 failed to inhibit Bad trans-
location to the mitochondrial fraction, suggesting that MKK7-
JNK (WT) promoted the translocation of endogenous Bad to
mitochondria independently of caspase activation.
We also determined whether UV induces Bad translocation
to the mitochondria through the activation of endogenous JNK.
The UV irradiation of HCT116 cells resulted in an increase in
endogenous Bad in the mitochondrial fraction (Fig. 3 c). More-
over, the expression of JBD inhibited this translocation of Bad
from the cytosol to the mitochondria (Fig. 3 c), supporting the
idea that JNK mediates cellular UV-induced Bad translocation.
If JNK promotes Bad translocation to the mitochondria
through phosphorylation of 14-3-3 proteins, the expression of a
14-3-3 mutant lacking the phosphorylation site should block
JNK-induced Bad translocation because the unphosphorylated
form of 14-3-3 should retain Bad in the cytoplasm. As ex-
pected, the coexpression of 14-3-3
 
 
 
 Ser184A, and to a lesser
extent of 14-3-3
 
 
 
 (WT), inhibited MKK7-JNK (WT)–induced
Bad translocation to the mitochondrial fraction (Fig. 3 d).
These results strongly suggest that 14-3-3 is an essential target
for JNK in promoting Bad translocation to the mitochondria.
 
JNK promotes the association of Bad 
with Bcl-2/Bcl-x
 
L
 
The BH3-only subfamily of Bcl-2 family proteins, including
Bad, has been postulated to promote apoptosis by antagoniz-
ing the antiapoptotic functions of Bcl-2/Bcl-x
 
L
 
 (Yang et al.,
1995; Danial and Korsmeyer, 2004). Because we found that
active JNK can induce Bad translocation to the mitochondria
through phosphorylation of 14-3-3, we next asked whether
JNK also induces Bad association with Bcl-2/Bcl-x
 
L
 
. When
endogenous Bad in healthy cells was immunoprecipitated with
anti-Bad antibody, small amounts of Bcl-2/Bcl-x
 
L
 
 were coim-
munoprecipitated (Fig. 4 a). In contrast, when MKK7-JNK
(WT), but not MKK7-JNK (KN), was expressed in these cells,
the amounts of endogenous Bcl-2/Bcl-x
 
L
 
 that was associated
with endogenous Bad greatly increased, corresponding to the
reduction of 14-3-3 associated with Bad (Fig. 4 a). If JNK pro-
motes the association of Bad with Bcl-2/Bcl-x
 
L
 
 through phos-
phorylation of 14-3-3, the expression of 14-3-3
 
 
 
 Ser184A
should block the JNK-induced interaction between Bad and
Bcl-2/Bcl-x
 
L
 
. Indeed, the expression of 14-3-3
 
 
 
 Ser184A in-
hibited the increase of Bad protein that interacted with Bcl-2/
Bcl-x
 
L
 
 (Fig. 4 b). Altogether, these results suggest that the acti-
vation of JNK induces the activation of Bad at the mitochondria
through phosphorylation of 14-3-3.
 
JNK regulates the phosphorylation state 
of Bad through 14-3-3
 
Although Bad is released from 14-3-3 by JNK-mediated 14-3-3
phosphorylation, this release by itself should not be sufficient for
its association in a complex of Bcl-2/Bcl-x
 
L 
 
because phosphory-
lation of Bad at Ser112, 136, or 155 has been shown to hamper
its association with Bcl-2/Bcl-x
 
L
 
 (Zha et al., 1996; Datta et al.,
Figure 3. Active JNK promotes Bad translocation to the mitochondria.
(a) COS-1 cells were transfected for 18 h with expression vectors for Myc-
Bad and p35 together with a vector for MKK7-JNK as indicated. They
were examined for the distribution of Myc-Bad (anti-Myc staining, green)
and mitochondria (CMXRos, red) by fluorescence microscopy; the two
separate images for each representative cell are shown superimposed
(overlay). (b) COS-1 cells were transfected for 18 h with expression vec-
tors for GFP and MKK7-JNK in the absence or presence of the vector for
p35 as indicated. The transfection efficiency was  75% as determined by
monitoring the expression of GFP. (c) HCT116 cells were transfected with
expression vectors for indicated plasmids and were irradiated by 50 J/m
2
UV for 6 h. (d) COS-1 cells were transfected for 18 h with expression vec-
tors for GFP, MKK7-JNK (WT), and either 14-3-3  (WT) or Ser184A as in-
dicated. (b–d) Then, the cells were subjected to subcellular fractionation,
and the amount of endogenous Bad in the mitochondrial and cytosolic
fractions was assessed by immunoblot analysis (IB) with antibodies to Bad.
The mitochondrial marker F1F0-ATPase and the cytosolic marker  -tubulin
were used as internal standards. The same results were obtained in three
independent experiments. 
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2000; Zhou et al., 2000). The finding that activation of JNK
results in the association of Bad with Bcl-2/Bcl-x
 
L
 
 prompted us
to examine the phosphorylation state of Bad in cells expressing
active JNK. Our most important finding was that the expression
of MKK7-JNK (WT) resulted in a gradual reduction in the level
of Bad phosphorylation at Ser112 and 136 (Fig. 4 c). The disso-
ciation between 14-3-3 and Bad started to take place 16 h after
the transfection of MKK7-JNK (WT), whereas the reduction of
Bad phosphorylation was evident at 
 
 
 
18 h after transfection
(Fig. 4 c). Phosphorylation of Bad at Ser155, which is a key site
inhibiting Bcl-2/Bcl-x
 
L
 
 binding, was also reduced by the ex-
pression of MKK7-JNK (WT; Fig. S2 a, available at http://
www.jcb.org/cgi/content/full/jcb.200409117.DC1). We do not
believe that JNK causes dephosphorylation of Bad by inactivat-
ing kinases that are responsible for Bad phosphorylation, be-
cause we observed that the expression of MKK7-JNK (WT) did
not reduce the activity of Akt or Rsk, two major kinases respon-
sible for Bad phosphorylation, under conditions where it reduced
Bad phosphorylation (Fig. S2 b).
Therefore, JNK appears to induce both the release of Bad
from 14-3-3 and the dephosphorylation of Bad. Is there any
causal relationship between these two events? To examine
this, we treated COS-1 cells with the phosphatase inhibitor
okadaic acid (OA) to prevent dephosphorylation of Bad at
Ser112 and 136 (Fig. 4 d). We confirmed that OA maintained
the level of Bad phosphorylation, yet we observed that the ex-
pression of MKK7-JNK (WT) still reduced the amount of 14-3-3
that is associated with Bad (Fig. 4 d). This suggests that de-
phosphorylation of Bad is not a prerequisite for the JNK-medi-
ated dissociation of Bad from 14-3-3. On the other hand, the
expression of 14-3-3
 
 
 
 Ser184A suppressed Bad dephosphory-
lation at Ser112 and 136 (Fig. 4 e). This strongly supports the
notion that Bad release from 14-3-3 is necessary for Bad de-
phosphorylation after JNK activation. Because Chiang et al.
(2003) has shown that 14-3-3 and protein phosphatase 2A
compete for Bad and that 14-3-3 maintains the phosphorylated
state of Bad, it is conceivable that the JNK-mediated release
from 14-3-3 makes Bad accessible to phosphatases and that it
is dephosphorylated as a result.
 
JNK-mediated 14-3-3 phosphorylation 
regulates Bad-dependent cell death
 
We next examined the relative contribution of the JNK-induced
phosphorylation of 14-3-3 to cell death regulation in a cellular
context in which cell death is dependent on Bad and is coun-
teracted by Akt. In HCT116 cells, UV-induced apoptosis,
which is dependent on JNK (Fig. 5, a and b), and MKK7-JNK
(WT)–induced apoptosis were suppressed by small interference
Figure 4. Expression of active JNK promotes association of Bad
with Bcl-2/Bcl-xL and regulates the phosphorylation state of Bad.
(a and b) COS-1 cells were transfected for 18 h with expression
vectors for MKK7-JNK and p35 (a) or for Myc–14-3-3  (WT or
Ser184A) and MKK7-JNK (b) as indicated and were subjected
either to immunoblot analysis (IB) with indicated antibodies or to
immunoprecipitation (IP) with antibodies to Bad; the resulting pre-
cipitates were subjected to immunoblot analysis with indicated
antibodies. (b) The asterisk indicates the position of Myc-tagged
14-3-3 . (c) COS-1 cells were transfected for the indicated times
with expression vectors for MKK7-JNK. (d) COS-1 cells were
transfected for 12 h with the indicated plasmids and were incu-
bated for 6 h in the absence or presence of 500 nM okadaic
acid (OA). (c and d) Cell lysates were subjected to immunopre-
cipitation with antibodies to Bad, and the resulting precipitates
were subjected to immunoblot analysis with indicated antibodies.
(e) COS-1 cells were transfected for 18 h with expression vectors
for MKK7-JNK (WT) and 14-3-3  Ser184A. Cell lysates were
subjected to immunoblot analysis as indicated. The same results
were obtained in two independent experiments. 
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RNA (siRNA) against Bad (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200409117.DC1), suggest-
ing that they are dependent on endogenous Bad, at least in
part. It is important to note that the expression of 14-3-3
 
 
 
Ser186A, and to a lesser extent the expression of 14-3-3
 
 
 
(WT), suppressed both UV-induced apoptosis (Fig. 5, c and d)
and MKK7-JNK (WT)–induced apoptosis (Tsuruta et al.,
2004). The ectopic expression of a low level of Bad caused
enhanced UV-induced apoptosis; and, again, this enhance-
ment was suppressed, in part, by the expression of 14-3-3
 
 
 
Ser186A and, to a lesser extent, by the expression of 14-3-3
 
 
 
(WT; Fig. 5 e). These results clearly indicate that 14-3-3 sup-
presses Bad-mediated apoptosis in a phosphorylation-depen-
dent manner.
In HCT116 cells, the survival-promoting effects of se-
rum appear to be mediated by the Akt pathway because the
expression of DN-Akt abrogated these effects (Fig. 6 a). The
survival-promoting effects of serum and CA-Akt were sup-
pressed by MKK7-JNK (WT), whereas the apoptosis-promoting
effects of MKK7-JNK (WT) were suppressed by serum and
CA-Akt (Fig. 6, a and b), indicating antagonistic interactions
between JNK and Akt in this cell line. The enhanced apoptosis
caused by serum deprivation or the expression of DN-Akt was
in part suppressed by siRNA against Bad (Fig. S4, available
at http://www.jcb.org/cgi/content/full/jcb.200409117.DC1).
Importantly, the expression of 14-3-3
 
 
 
 Ser186A also sup-
pressed apoptosis that was induced by serum deprivation and
DN-Akt and did so more effectively than 14-3-3
 
 
 
 (WT; Fig.
6, c and d). These results support the notion that 14-3-3 sup-
presses Bad-mediated apoptosis in a phosphorylation-depen-
dent manner in a context in which serum promotes cell survival
via the Akt pathway.
Figure 5. JNK-mediated 14-3-3 phosphorylation regulates Bad-dependent
cell death. HCT116 cells were transfected with the indicated plasmids
together with a GFP-expressing plasmid for 12 h and were irradiated by
50 J/m
2 UV for 6 h (a–d) or for 3 h (e). The cells were stained with
Hoechst 33342 for 10 min (a, c, and e). The percentage of GFP-positive
cells with pyknotic nuclei was determined. Data shows the means   SD of
values obtained from three fields of 150–200 cells in each of three inde-
pendent experiments. (a and c) *, P   0.01; (e) *, P   0.05. At least
750 cells (a), 600 cells (c), and 500 cells (d) per sample were analyzed.
(b and d) Cell lysates were subjected to immunoblot analysis (IB) with the
indicated antibodies. p19 and p17 fragments represent cleaved (and acti-
vated) caspase-3. SA, Ser186A.
Figure 6. Antagonistic interaction between Akt and JNK in the regulation
of cell death. (a) HCT116 cells were transfected with expression vectors
for GFP, MKK7-JNK (WT), and Akt mutants and were incubated with or
without 10% serum for 6 h. Then, they were stained with Hoechst 33342
and were subjected to cell death assay by the detection of chromatin con-
densation. The right panel shows that endogenous Akt was dephosphory-
lated 6 h after serum deprivation. At least 540 cells (a) and 480 cells (b)
per sample were analyzed (*, P   0.01 and **, P   0.04). (b) HCT116
cells were transfected with expression vectors for GFP, CA-Akt, and the in-
dicated amounts of MKK7-JNK (WT) and were incubated with or without
10% serum for 6 h. (c and d) HCT116 cells were transfected with the indi-
cated plasmids together with a GFP-expressing plasmid for 20 h. Then,
they were incubated with or without 10% serum for 8 h (d) when neces-
sary and were subjected to cell death assay by the detection of chromatin
condensation. (c) *, P   0.05; (d) *, P   0.001; and **, P   0.04. At
least 460 cells (c) and 640 cells (d) per sample were analyzed. (a–d)
Data are means   SD (error bars) of values obtained from three fields of
150–200 cells in each of three independent experiments. 
JNK ANTAGONIZES AKT VIA 14-3-3 • SUNAYAMA ET AL.
 
301
 
JNK-mediated 14-3-3 phosphorylation 
affects another 14-3-3 ligand: FOXO3a
 
As mentioned previously, many 14-3-3 ligands bind to the
common ligand-binding groove of 14-3-3 and share 14-3-3–
binding motifs. It is likely, therefore, that JNK-mediated phos-
phorylation results in the dissociation of 14-3-3 ligands other
than just Bad. To test this idea, we examined whether the JNK-
mediated phosphorylation of 14-3-3 releases FOXO3a from
14-3-3 (Fig. S5, available at http://www.jcb.org/cgi/content/
full/jcb.200409117.DC1), as Akt inactivates the proapoptotic
protein FOXO3a by direct phosphorylation, inducing its asso-
ciation with 14-3-3 (Brunet et al., 1999). In an in vitro recon-
stitution assay, Akt-mediated phosphorylation increased the
amount of GST-FOXO3a that was coprecipitated with His–
14-3-3
 
 
 
. However, phosphorylation of 14-3-3
 
 
 
 by MKK7-JNK
(WT) reduced the amount of FOXO3a that was coprecipitated
with 14-3-3
 
 
 
 even when FOXO3a was phosphorylated by Akt.
On the other hand, when the Ser184A mutant of His–14-3-3
 
 
 
was used, similar amounts of FOXO3a were precipitated with
or without preincubation with MKK7-JNK (WT), suggesting
that direct 14-3-3
 
  
 
phosphorylation at Ser184 by JNK reduces
its affinity for FOXO3a. Although we found that the expression
of FOXO3a promoted apoptosis, which was suppressed by the
expression of 14-3-3 in a Ser184-dependent manner, the down-
regulation of endogenous FOXO3a expression by RNA inter-
ference (RNAi) did not affect apoptosis that was induced by
UV treatment in our preliminary experiments (unpublished
data). Therefore, we think that FOXO3a may not be a key me-
diator in UV-induced apoptosis in this cell line, although this
result does not rule out the possible existence of proapoptotic
factors that function redundantly with FOXO3a in this system.
In fact, several 14-3-3–binding proteins in extracts that were
prepared from [
 
35
 
S]methionine-labeled COS-1 cells were dis-
sociated from GST–14-3-3
 
 
 
 when subjected to the JNK-medi-
ated phosphorylation of GST–14-3-3
 
 
 
 at Ser184 in an in vitro
GST pull-down assay (Fig. 7). This suggests that JNK regu-
lates these 14-3-3–binding proteins in concert.
 
Discussion
14-3-3: an integration point of survival 
and apoptotic signals
In this study, we described a novel mechanism by which the
JNK signaling pathway regulates cell death. We found that the
JNK-mediated phosphorylation of 14-3-3 releases Bad from
14-3-3 and induces its translocation to mitochondria and its as-
sociation with Bcl-2/Bcl-xL, which presumably results in their
inactivation. It is important to note that this phosphorylation
also leads to the release of several 14-3-3 ligands from 14-3-3,
including the proapoptotic protein FOXO3a. Because many
proapoptotic proteins share a common 14-3-3–binding motif
(RSXpSXP or RXXXpSXP) and the JNK phosphorylation site
in 14-3-3 resides in the vicinity of its ligand-binding groove, it is
likely that JNK phosphorylation affects this ligand-binding site,
leading to the release and consequent activation of these proap-
optotic proteins through a common mechanism. Our results sup-
port the notion that the JNK-mediated phosphorylation of 14-3-3
affects the activities of a broad range of 14-3-3 ligands, ulti-
mately leading to the onset of the cell death program.
Recent studies have shown that JNK directly phosphory-
lates Bad at Ser128 and Thr201 (Donovan et al., 2002; Konishi
et al., 2002; Yu et al., 2004). Phosphorylation of the former res-
idue reduces the affinity of Bad for 14-3-3 and activates Bad,
whereas phosphorylation of the latter reduces the affinity of
Bad for Bcl-2/Bcl-xL and inactivates Bad. We found that the
JNK-mediated phosphorylation of 14-3-3 reduced its interac-
tion with WT and Ser128A Bad proteins to a similar extent.
This suggests that JNK can cause the release of Bad from 14-3-3
independently of phosphorylation at Bad Ser128. However, it
is possible that these two JNK-mediated phosphorylations
(on Bad and 14-3-3) act in parallel or in a concerted fashion to
Figure 7. Phosphorylation of 14-3-3  at Ser184 by JNK releases a subset
of 14-3-3 –binding proteins. COS-1 cells were transfected for 12 h with
either an expression vector for Flag-tagged MKK7-JNK (WT) or control
vector and were incubated for 1 h in the presence of either 10  g/ml ani-
somycin or DMSO. Flag-tagged MKK7-JNK (WT) was immunoprecipitated
from cell lysates with antibodies to Flag and were incubated with recom-
binant GST, GST–14-3-3  (WT), or Ser184A in the presence of ATP for
45 min. These GST proteins were incubated for 2 h with [
35S]methionine-
labeled COS-1 cell lysates. The GST proteins were precipitated using glu-
tathione–Sepharose beads, and the bound proteins were resolved by 10%
SDS-PAGE and were detected by autoradiography and by staining with
Coomassie brilliant blue (CBB). Essentially the same results were obtained
in at least two independent experiments. In control experiments (vector  
DMSO), many proteins were found to be associated with GST–14-3-3 
(WT) and GST–14-3-3  Ser184A, but not with GST alone. A subset of
these proteins did not associate with JNK-phosphorylated GST–14-3-3 
(WT). This dissociation appears to be dependent on the phosphorylation
of 14-3-3  at Ser184 because GST–14-3-3  Ser184A associated with al-
most the same set of proteins regardless of whether it was phosphorylated
by JNK or not. The proteins that dissociated from GST–14-3-3  (WT) upon
JNK phosphorylation also did not bind to the GST–14-3-3  mutant (K49E),
which harbors a point mutation within the common ligand-binding groove.
This strongly supports the notion that JNK phosphorylation of 14-3-3  at
Ser184 releases typical 14-3-3 ligands.JCB • VOLUME 170 • NUMBER 2 • 2005 302
effectively activate Bad. Thr201, on the other hand, exists in
mouse Bad but not in human Bad and may not be generally
involved in Bad regulation.
There appears to be some threshold below which apop-
totic signaling can occur but cannot lead to cell death. In this
context, 14-3-3 can function to raise this hypothetical threshold
by acting as a “buffer” that sequesters several proapoptotic pro-
teins in response to survival signals, including those mediated
by Akt. This is also consistent with the observation that in-
creasing or decreasing the amount of available 14-3-3 can shift
the balance between survival and apoptosis, in effect raising or
lowering the threshold for apoptotic signaling. There would be
at least three ways to override the threshold set by 14-3-3. The
first and probably the simplest way is to increase the total
amount of proapoptotic proteins so that they exceed the thresh-
old level. The second way is to reduce the amount of survival
signals, which would result in dephosphorylation and release of
proapoptotic proteins from 14-3-3 (Fig. 8 b). The third way is
to reduce the level of available 14-3-3 by the JNK-mediated
phosphorylation of 14-3-3, resulting in the release of proapop-
totic proteins (Fig. 8 c). In this scenario, JNK functions to
lower this hypothetical threshold, thus rendering cells more
susceptible to apoptotic signals.
As mentioned previously, the balance between apoptosis
and survival signals is essential for understanding cell death
regulation. We propose that 14-3-3 may serve as a key integra-
tion point of both JNK-mediated stress signals and Akt-medi-
ated survival signals, and thus contributes to the decision
whether a cell should live or die.
Materials and methods
Materials
Anisomycin was obtained from Sigma-Aldrich, OA was obtained from
Calbiochem, and CMXRos was obtained from Molecular Probes.
Cell culture and transfection
COS-1 cells were maintained in DME (Sigma-Aldrich) supplemented with
10% FBS and 1% penicillin/streptomycin. HCT116 cells were maintained
in McCoy’s 5A Medium (Sigma-Aldrich) with 10% FBS, 1% penicillin/
streptomycin, and 1.5 mM L-glutamine. COS-1 cells were transfected with
plasmids by the use of Fugene6 (Roche Diagnostics), and HCT116 cells
were transfected with LipofectAMINE 2000 (Invitrogen).
Plasmid construction
The constructs encoding mice Bad (full length) and FOXO3a (aa 1–525)
were provided by M.E. Greenberg (Harvard Medical School, Boston,
MA). We obtained the constructs encoding 14-3-3  from H. Fu (Emory
University School of Medicine, Atlanta, GA) and obtained 14-3-3  from B.
Vogelstein (The Johns Hopkins University School of Medicine, Baltimore,
MD). For the Myc-tagged Bad expression vector, the Bad cDNA fragment
was inserted into the BglII site of pCS4-Myc. Site-directed mutagenesis
was performed with the QuikChange kit (Stratagene) to generate the
Ser128 and Thr201 into Ala change in Bad and to generate the Lys49
into Glu change in 14-3-3 . WT, Ser128A, Thr201A, and Ser128A-
Thr201A Bad cDNA were cloned into the BamHI sites of pET28a
(Novagen), and K49E 14-3-3  cDNA was cloned into the BglII site of
pCS4-Myc. pcDNA3-MKK7-FLAG-JNK (WT and KN), pET28a-MKK7-
FLAG-JNK (WT and KN), pGEX6P-1–14-3-3  (WT and Ser184A), pCS4-
Myc–14-3-3  (WT and Ser184A), pCS4-Myc–14-3-3  (WT and
Ser186A), the constructs encoding p35 (a gift from M. Miura, University
of Tokyo, Tokyo, Japan), CA-Akt, DN-Akt, WT-Akt, DN-JNK, and DN-JBD
(a gift from R. Davis, University of Massachusetts Medical School, Worces-
ter, MA) have been described previously (Masuyama et al., 2001; Tsuruta
et al., 2002, 2004).
Antibodies
Antibodies to 14-3-3 (K-19; Santa Cruz Biotechnology, Inc.), 14-3-3 
(C-18; Santa Cruz Biotechnology, Inc.), Bad (C-20; Santa Cruz Biotech-
nology, Inc.), phospho-Bad (Ser112; Cell Signaling), phospho-Bad
(Ser136; Cell Signaling), Bcl-2 (N-19; Santa Cruz Biotechnology, Inc.),
Bcl-xL (S-18; Santa Cruz Biotechnology, Inc.), cleaved caspase-3 (Cell
Signaling), F1F0-ATPase subunit   (7H10; Molecular Probes),  -tubulin
(DM1A; Sigma-Aldrich), GAPDH (MAB374; Chemicon), GST (B-14;
Santa Cruz Biotechnology, Inc.), c-Jun (Cell Signaling), phospho–c-Jun
(Cell Signaling), Akt (Cell Signaling), phospho-Akt (Ser473; 58F11; Cell
Signaling), Rsk (Upstate Biotechnology), or phospho-p90Rsk (Thr359-
Ser363; Cell Signaling) were used for immunoblot analysis. An antibody
to phospho-Bad (Ser155) was provided by M.E. Greenberg (Datta et al.,
2000). Antibodies to Bad (C-20; Santa Cruz Biotechnology, Inc.), 14-3-3 
(C-18; Santa Cruz Biotechnology, Inc.), HA (Y-11; Santa Cruz Biotech-
nology, Inc.), Flag (M2; Sigma-Aldrich), normal rabbit IgG (Santa Cruz
Figure 8. A model for antagonism between
Akt (survival) and JNK (apoptotic) signals via
14-3-3 proteins. (a) Exposure of a cell to sur-
vival signals results in inhibiting apoptosis by
the 14-3-3–mediated sequestration of Akt-
phosphorylated proapoptotic proteins such as
Bad and FOXO3a. (b) Reduced survival sig-
nals promote dephosphorylation of proapop-
totic proteins, resulting in the release of these
proteins from 14-3-3 and, thus, leading to cell
death. (c) Potent (sustained) apoptotic signals
promote JNK-mediated phosphorylation of
14-3-3, resulting in the release of proapoptotic
proteins from 14-3-3 and cell death. P shown
in pink and blue circles represents Akt- and
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Biotechnology, Inc.), or normal goat IgG (Santa Cruz Biotechnology,
Inc.) were used for immunoprecipitation.
Immunoblot analysis
Cells were washed with PBS and were lysed in an extraction buffer (20 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM  -glycerophosphate, 5 mM
EGTA, 1 mM sodium pyrophoshate, 5 mM NaF, 1 mM Na3VO4, 0.5%
Triton X-100, and 1 mM DTT) supplemented with protease inhibitors (1 mM
PMSF, 5  g/ml leupeptin, 5  g/ml pepstatin A, and 5  g/ml aprotinin).
Proteins were separated by SDS-PAGE and were electrically transferred to
a polyvinylidene difluoride membrane. The membrane was probed with
the appropriate primary antibody and with an HRP-conjugated secondary
antibody. Blots were visualized by Western Lightning (PerkinElmer).
Protein purification
His6-tagged Bad (WT, Ser128A, Thr201A, or Ser128A-Thr201A) was ex-
pressed in Escherichia coli BL21 by pET28a-based vectors. After IPTG was
added, induction occurred; and His-tagged proteins were purified with
Ni
2 -bound column (ProBond resin; Invitrogen). The purification of GST–
14-3-3 , GST-FOXO3a (aa 1–525), and His6-tagged MKK7-JNK was per-
formed as described previously (Brunet et al., 1999; Tsuruta et al., 2004).
Subcellular fractionation
Cells were washed with PBS, suspended in 300  l of ice-cold isotonic
buffer (200 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM Hepes-
NaOH, pH 7.4, and 1 mM DTT) supplemented with the protease inhibi-
tors described above, and homogenized with a Potter-Elvehjem homoge-
nizer (model Mazela Z; Eyela). Nuclei and unbroken cells were removed
by centrifugation at 500 g for 10 min, and the supernatant was further
centrifuged at 100,000 g for 60 min. The resulting supernatant was saved
as the cytosolic fraction, and the pellet was washed with isotonic buffer,
resuspended in extraction buffer supplemented with protease inhibitors,
and centrifuged at 20,000 g for 5 min to remove debris. The resulting su-
pernatant was saved as the mitochondrial fraction.
Coimmunoprecipitation assay
COS-1 cells were lysed in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 10 mM  -glycerophosphate, 5 mM EGTA, 1 mM sodium pyrophos-
hate, 5 mM NaF, 1 mM Na3VO4, 0.05% Triton X-100, and 1 mM DTT).
The lysates were then incubated with antibodies to Bad (C-20) for 1 h and
were subsequently incubated with protein A–Sepharose beads (GE Health-
care) for 1 h. HCT116 cells were lysed in the lysis buffer described above,
and the lysates were precleared with protein G–Sepharose beads (GE
Healthcare). The lysates were incubated with antibodies to 14-3-3  (Santa
Cruz Biotechnology, Inc.) and with protein G–Sepharose beads for 2 h. The
protein–antibody complexes that were recovered on beads was subjected
to immunoblot analysis after separation by SDS-PAGE.
GST pull-down assay
Recombinant GST–14-3-3  (WT or Ser184A) was incubated with or with-
out purified MKK7-JNK (WT or KN) in the presence of a kinase reaction
buffer (100  M ATP, 20 mM Tris-HCl, pH 7.5, and 15 mM MgCl2) for
30 min at 30 C. His6-Bad (WT, Ser128A, Thr201A, or Ser128A-
Thr201A) protein was preincubated with or without active Akt immunopre-
cipitate in a kinase reaction buffer. Subsequently, Bad protein was mixed
with GST–14-3-3  and glutathione–Sepharose 4B beads for 1 h at 4 C,
and the bead-bound proteins were subjected to immunoblot analysis with
antibodies to Bad and GST.
Immunofluorescence analysis
COS-1 cells were grown on poly-D-lysine–coated coverslips and were
transfected with a plasmid expressing Myc-tagged Bad and p35 and/
or expression plasmids encoding MKK7-JNK proteins. Cells were fixed
in PBS containing 4% PFA for 10 min at RT. The fixed coverslips were
permeabilized in PBS containing 0.5% Triton X-100 for 10 min,
washed twice in PBS, and incubated in a blocking solution (PBS con-
taining 2% BSA) for 30 min. The cells were then incubated in the block-
ing solution with anti-Myc antibody (9E10; Santa Cruz Biotechnology,
Inc.) for 1 h and with AlexaFluor488 anti–mouse IgG antibody (Molec-
ular Probes) for 1 h in the blocking solution. Where indicated, cells
were stained with CMXRos before fixation to visualize mitochondria.
Fluorescence images were recorded by a confocal laser-scanning mi-
croscope (model LSM-510; Carl Zeiss MicroImaging, Inc.). All images
were captured at 40  by using objective lenses (1.4 NA; C-Apochromat).
Pictures were analyzed by using LSM5 Image Browser (Carl Zeiss Mi-
croImaging, Inc.).
RNAi experiment
The siRNA for human Bad mRNA was obtained from Japan Bio Services
Co., Ltd. The siRNA sequences used in this study for Bad were sense
(5 -UGAGUGACGAGUUUGUGGAdTdT-3 )  and antisense (5 -UCCA-
CAAACUCGUCACUCAdTdT-3 ). The 5  terminus of the sense sequence
was labeled with Texas red, and the sequences were randomized for the
control siRNA (sense, 5 -AGUUCGAUUUUAGGGGGGAdTdT-3 ; anti-
sense, 5 -UCCCCCCUAAAAUCGAACUdTdT-3 ). Transfection to HCT116
cells was performed using Oligofectamine reagent (Invitrogen) according
to the manufacturer’s instructions except that the incubation time with
transfection reagents was 120 min. The transfection efficiency was
 95%, as assessed by Texas red.
Apoptosis assay
HCT116 cells were seeded into 60-mm culture dishes and were trans-
fected with a plasmid expressing GFP together with expression plasmids
encoding JBD, Bad, MKK7-JNK (WT), and various Akt or 14-3-3 proteins.
After 24 h, cells were irradiated by UV for 6 h when necessary in the pres-
ence of 10% serum for 6 h. After staining with Hoechst 33342 for 10 min,
the percentage of GFP-positive cells with a pyknotic nucleus was deter-
mined. For the RNAi experiments, 2.5   10
5 cells were seeded into 35-
mm dishes and were transfected with 100 pmol siRNA. After 36 h, cells
were transfected with 0.625  g of expression vectors for GFP, MKK7-JNK
(WT), or various Akt proteins or, after 48 h, cells were irradiated by UV.
Then, they were stained with Hoechst 33342.
Statistical analysis
Results were expressed as the mean   SD and were analyzed by using
the unpaired t test.
Online supplemental material
Fig. S1 shows that the JNK-mediated phosphorylation of 14-3-3 can in-
duce the dissociation of Bad regardless of the Ser128 and Thr201 phos-
phorylation of Bad in vitro. Fig. S2 shows that the expression of active
JNK results in the reduction of Bad phosphorylation at Ser112, 136, and
155 without inhibiting phosphorylation of Akt and Rsk. Fig. S3 shows that
UV- and active JNK-induced cell death is partially dependent on Bad.
Fig. S4 shows that the introduction of siRNA against Bad suppressed cell
death, which is induced by serum deprivation or DN-Akt. Fig. S5 shows
that the JNK-mediated phosphorylation of 14-3-3  results in the release of
FOXO3a from 14-3-3  in vitro. Online supplemental material is available
at http://www.jcb.org/cgi/content/full/jcb.200409117.DC1.
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